Total Liabilities: The total value of all possible claims against the corporation.
Lixte Biotechnology Holdings, Inc. (LIXT) had Total Liabilities of $0.36M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.71M |
|
-- |
|
-- |
|
$0.71M |
|
$-0.71M |
|
$-0.00M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
2.47M |
|
2.47M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$1.51M |
|
-- |
|
-- |
|
$1.51M |
|
$0.36M |
|
-- |
|
-- |
|
|
Total Liabilities |
$0.36M |
$-2.34M |
|
$1.16M |
|
$1.16M |
|
2.68M |
|
| Cash Flow Statement Financials | |
$-0.57M |
|
-- |
|
$0.91M |
|
$1.04M |
|
$1.38M |
|
$0.35M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
30.31% |
|
-61.21% |
|
-46.86% |
|
-61.21% |
|
$0.43 |
|
$-0.23 |
|
$-0.23 |
|